Galuska D., Nolte LA, Zierath JR, Wallberg-Henriksson H.Effect of metformin on insulin-stimulated glucose transport in isolated skeletal muscle obtained from patients with NIDDM. Diabetologia1994;37:826-32.
2.
Nagi DK, Yudkin JSEffects of metformin on insulin resistance, risk factors for cardiovascular disease, and plasminogen activator inhibitor in NIDDM subjects. Diabetes Care1993;16(4): 621-29.
3.
Jeppsen J., Zhou MY, Chen Ydi, Reaven GMEffect of metformin on postprandial lipemia in patients with fairly to poorly controlled NIDDM. Diabetes Care1994;17(10):1093-98.
4.
Schneider J.Erren T., Zofel P., Kaffarnik H.Metformin-induced changes in serum lipids, lipoproteins, and apoproteins in non-insulin-dependent diabetes mellitus. Atherosclerosis1990;82:97-103.
5.
Johnson AB, Webster JM, Sum CF, et al. The impact of metformin therapy on hepatic glucose production and skeletal muscle glycogen synthase activity in overweight type II diabetic patients. Metabolism1993;42(9):1217-22.
6.
Wu MSJohnston P., Sheu WH, et al. Effect of metformin on carbohydrate and lipoprotein metabolism in NIDDM patients. Diabetes Care1990;13(1):1-8.
7.
Reaven GM, Johnston P., Hollenbeck CB, et al. Combined metformin-sulfonylurea treatment of patients with non-insulin-dependent diabetes in fair to poor glycemic control. J Clin Endocrinology Metab1992;74(5):1020-26.
8.
Herman LS, Schersten B., Bitzen PO, Kjellstrom T., Lindgarde F., Melander A.Therapeutic comparison of metformin and sulfonylurea, alone and in various combinations. Diabetes Care1994;17(10):1100-9.
9.
Pentikainen PJ, Neuvonen PJ, Penttila A.Pharmacokinetics of metformin after intravenous and oral administration to man. Eur J Clin Pharmacol1979;16:195-202.
10.
Josephkutty S., Potter JMComparison of tolbutamide and metformin in elderly diabetic patients. Diabetic Med1990 ;7:510-14.
11.
Tucker GT, Casey C., Phillips PJConnor H., Ward JDWoods HFMetformin kinetics in healthy subjects and in patients with diabetes mellitus . Br J Clin Phannacol1981;12:235-46.
12.
Lalau JD, Vermersch A., Hary L., Andrejak M., Isnard F., Quichaud J.Type 2 diabetes in the elderly: an assessment of metformin (metformin in the elderly). Int J Clin Pharmacol Ther Toxicol1990;28(8):329-32.
13.
Bailey CJBiguanides and NIDDM. Diabetes Care1992;15(6):755-71.
14.
Guigliano D. , Quatraro A., Consoli G., Ceriello A., De Rosa N., D'Onofrio F.Metformin for obese, insulin-treated diabetic patients: improvement in glycaemic control and reduction of metabolic risk factors. EurJ Clin Pharmacol1993;44:107-12.
15.
Trischitta V., Italia S., Mazzarino S., et al. Comparison of therapies in treatment of secondary failure to glyburide. Diabetes Care1992;15(4): 539-42.
16.
Bailey C.Metformin — an update. Gen Pharmacol1993;24(6):1299-1309.
17.
Frayn KN, Adnitt PI, Turner P.The hypoglycaemic action of metformin. Postgrad Med J1971;47:777-80.
18.
Somoygi A., Stockley C., Keal J., Rolan P., Bochner F.Reduction of metformin renal tubular secretion by cimetidine. Br J Clin Pharmacol1987;23:545-61.
